Ancora Advisors, LLC Takeda Pharmaceutical CO LTD Transaction History
Ancora Advisors, LLC
- $4.37 Billion
- Q2 2025
A detailed history of Ancora Advisors, LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Ancora Advisors, LLC holds 1,413 shares of TAK stock, worth $20,559. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,413Holding current value
$20,559% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TAK
# of Institutions
370Shares Held
73MCall Options Held
1.68MPut Options Held
157K-
Capital Research Global Investors Los Angeles, CA13.3MShares$193 Million0.04% of portfolio
-
Morgan Stanley New York, NY7.62MShares$111 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.5MShares$65.5 Million0.01% of portfolio
-
Ubs Group Ag4.02MShares$58.6 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.71MShares$54 Million0.54% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $45.2B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...